Candel Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Candel Therapeutics generated cash of -$34,244,000, which is less than the previous year. Cash used in financing activities reached the amount of -$121,000 last year. Net change in cash is therefore -$34,645,000.
Cash Flow
| 2019 | -5.17M | -35.74M | 21.97M |
|---|---|---|---|
| 2020 | -9.07M | 38.45M | 490K |
| 2021 | -22.21M | -1.83M | 71.8M |
| 2022 | -31.41M | -1.29M | 19.97M |
| 2023 | -34.24M | -280K | -121K |
CADL Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 70.32M | 83.06M | 35.31M | 5.44M | 24.38M |
Operating activities | |||||
Net income | -37.93M | -18.79M | -36.12M | -17.68M | -8.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 960K | 778K | 232K | 91K | 43K |
Stock-based compensation expense | 3.09M | 2.30M | 2.96M | 2.10M | 400K |
| Deferred income tax benefit | 3.09M | 2.30M | 2.96M | 2.10M | 400K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 45K | -1.21M | 669K | 289K | 13K |
Cash generated by operating activities | -34.24M | -31.41M | -22.21M | -9.07M | -5.17M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | -6K | -39.10M |
Investments In Property Plant And Equipment | -457K | -1.29M | -1.83M | -1.47M | -159K |
Acquisitions Net | 0 | 0 | 0 | -39.93M | -846K |
Cash generated by investing activities | -280K | -1.29M | -1.83M | 38.45M | -35.74M |
Financing activities | |||||
Common Stock Issued | 0 | 64K | 71.33M | 30K | 22.50M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -121K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 19.91M | 0 | -460K | 0 |
Cash used in financing activities | -121K | 19.97M | 71.8M | 490K | 21.97M |
Net Change In Cash | -34.64M | -12.74M | 47.74M | 29.87M | -18.93M |
Cash at end of period | 35.67M | 70.32M | 83.06M | 35.31M | 5.44M |
| Data source | Data source | Data source |